Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The Food and Drug Administration may require data from additional clinical trials before approving updated Covid-19 vaccines for healthy Americans younger than 65, according to new rules detailed on ...

The change means that Covid-19 boosters will likely be available in the fall for adults ages 65 and older and those with underlying conditions that may put them at higher risk of a Covid-19 infection...